Prolactinoma Outcome After Pregnancy and Lactation: A Cohort Study

Area of Science:

• Endocrinology
• Reproductive Medicine
• Oncology

Background:

• Prolactinoma, a common pituitary tumor in women of childbearing age, requires understanding of its behavior during and after pregnancy.
• Limited research exists on prolactinoma outcomes post-gestation.

Purpose of the Study:

• To investigate the spontaneous remission rate of prolactinomas after pregnancy and/or lactation.
• To assess changes in prolactinoma tumor size following gestation.

Main Methods:

• A retrospective study of 25 women with prolactinomas who conceived while on dopamine agonist (cabergoline) therapy.
• Cabergoline was discontinued in 24 pregnancies and continued in 7. Serum prolactin levels and MRI tumor size were evaluated post-delivery/lactation.

Main Results:

• Spontaneous remission of hyperprolactinemia occurred in 41.6% of cases where cabergoline was stopped during pregnancy.
• Tumor size reduction was observed in 25% of patients; 33% showed no change, and 42% had less than 50% reduction.
• Longer pre-pregnancy cabergoline treatment duration and smaller initial tumor size were associated with higher remission rates.

Conclusions:

• Pregnancy can induce remission in a significant proportion of prolactinomas.
• Factors such as extended dopamine agonist therapy duration and smaller pre-pregnancy adenoma size may predict successful remission.